1Zendman A J,Vossenaar ER,van Venrooij WJ.Autoantibodies to citrullinated (poly) peptidos:a key diagnostic and prognostic marker for rheumatoid arthritis[J].Autoimmunity,2004,37(4):295-299.
2Mimori T.Clinical significance of anti-CCP antibodies in rheumatoid arthritis[J].Intern Med,2005,44(11):1122-1126.
7Kroot EJ,et al.The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent onset rheunmatoid arthritis[J]Arthritis Rleum,2000,43(8):1831-1835.
6Vincent C,Simon M,et al. Immunoblotting deteccttion of autoantibodies to human epidermis filaggrin:a new diagnostic test for rheumatoid arthritis[J]. J Rheumatol, 1998,25:838-846.
7Saraux A ,Berthelot JM ,Chaies G ,et al. Value of laboratory test in early prediction of rheumatoid arthritis[J]. Arthritis Rheum, 2002; 47:155-165.
8Menard HA, Lapointe E, Rochdi MA,et al. Insights into rheumatoid arthritis derived from the Sa immune system[J]. Arthritis Res, 2000, 2:429-432.
9Schellekens GA,Visser H,de Jong BAW,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citurullnated peptide[J].Arthritis Rheum, 2000;43:155-163.
10Nogueira L,Sebbag M,Vincent C,et al. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or demanded recombinat human filaggrin, in the diagnosis of rheumatoid arthritis[J]. Ann Reum Dis,2001;60:882-887.